2010
DOI: 10.1086/655785
|View full text |Cite
|
Sign up to set email alerts
|

Paucity of Initial Cerebrospinal Fluid Inflammation in Cryptococcal Meningitis Is Associated with Subsequent Immune Reconstitution Inflammatory Syndrome

Abstract: Background Cryptococcal meningitis (CM)-related immune reconstitution inflammatory syndrome (IRIS) complicates antiretroviral therapy (ART) in 20–40% of ART-naïve persons with AIDS and prior CM. Pathogenesis is unknown. Methods We compared initial CSF cultures, inflammatory markers and cytokine profiles in ART-naïve AIDS patients who did or did not subsequently develop IRIS after starting ART. We also compared results obtained at IRIS events or CM-relapse. Results Of 85 subjects with CM, 33 (39%) developed… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

10
206
3
2

Year Published

2011
2011
2019
2019

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 178 publications
(221 citation statements)
references
References 45 publications
10
206
3
2
Order By: Relevance
“…Notably, in that study, median CD4 counts were higher than those in patients who did not develop IRIS (299). Unlike in HIV-positive patients, neither initial CSF cryptococcal antigen (CRAG) titers nor CSF leukocyte counts and protein levels differed from those in patients who did not develop IRIS (299,300). However, since patients with C. gattii who subsequently developed IRIS all presented with cryptococcomas in the brain, CSF parameters likely did not reflect the fungal load (or immune response) in this site.…”
Section: Immune Reconstitution Inflammatory Syndromementioning
confidence: 57%
“…Notably, in that study, median CD4 counts were higher than those in patients who did not develop IRIS (299). Unlike in HIV-positive patients, neither initial CSF cryptococcal antigen (CRAG) titers nor CSF leukocyte counts and protein levels differed from those in patients who did not develop IRIS (299,300). However, since patients with C. gattii who subsequently developed IRIS all presented with cryptococcomas in the brain, CSF parameters likely did not reflect the fungal load (or immune response) in this site.…”
Section: Immune Reconstitution Inflammatory Syndromementioning
confidence: 57%
“…Clinical evidence increasingly suggests that the host inflammatory response, rather than pathogen burden, may lead to the development of pathology, neuronal injury, and deteriorating status, especially in IRIS and PIIRS patients (28,30,32,33,(36)(37)(38)(39)(40). Thus, our next goal was to evaluate CNS pathology during the progression of C. neoformans infection and to determine a possible link to the accumulation of a cellular inflammatory response within the CNS.…”
Section: Resultsmentioning
confidence: 99%
“…T cell inflammatory response in the CNS during cryptococcal meningoencephalitis is highly Th1 polarized, and nearly all CD4 ؉ and CD8 ؉ T cells produce IFN-␥. The subsets of patients with paradoxical inflammatory responses to cryptococcal infection (IRIS and PIIRS) display dominant Th1 T cell polarization with elevated levels of IFN-␥ in the serum and CSF (32,33,(36)(37)(38)(39)(40). Thus, we sought to determine whether murine brain-infiltrating T cells would mimic this phenotype by analyzing T cell cytokine production and expression of polarizing Th-associated transcription factors in the C. neoformans-infected CNS.…”
Section: Resultsmentioning
confidence: 99%
“…It is hypothesized that the increase in mortality is related to immune reconstitution inflammatory syndrome (IRIS) and that the impact is greater earlier in the course of treatment, when the patient has not yet begun to recover from the original intracerebral insult and has limited reserves. In keeping with this theory, Boulware et al noted that the increased mortality was especially pronounced in patients with a baseline CSF white cell count <5 cells/mm 3 [176•], an established risk factor for IRIS [179,180].…”
Section: Antifungal Therapy-a Model For Clinical Researchmentioning
confidence: 99%